pyrazines has been researched along with tak 029 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (75.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushi, H; Imura, Y; Kawamura, M; Kita, S; Moriya, N; Nishikawa, K; Sugihara, H; Terashita, Z | 1 |
| Kawamura, M; Moriya, N; Terashita, Z; Tsuji, N | 1 |
| Iwasa, S; Kurokawa, T; Miyazaki, K; Ogawa, Y; Takada, S | 1 |
| Fujisawa, Y; Fukushi, H; Imai, Y; Kawamura, M; Kita, S; Miyawaki, T; Sugihara, H; Terashita, Z | 1 |
| Fujimura, A; Fuse, K; Kawahito, K; Kobayashi, E; Misawa, Y | 1 |
| Coleman, JC; Coller, BS; Hillman, RS; Lee, TT; Lincoff, AM; Smith, JW; Steinhubl, SR | 1 |
| Abe, T; Fukuuchi, Y; Inoue, K; Satoh, H; Tanahashi, N; Tomita, M; Tomita, Y | 1 |
| Affeld, K; Dohmen, PM; Kertzscher, U; Konertz, W; Linneweber, J | 1 |
8 other study(ies) available for pyrazines and tak 029
| Article | Year |
|---|---|
Antithrombotic effects of TAK-029, a novel GPIIb/IIIa antagonist, in guinea pigs: comparative studies with ticlopidine, clopidogrel, aspirin, prostaglandin E1 and argatroban.
Topics: Alprostadil; Animals; Arginine; Aspirin; Clopidogrel; Dogs; Fibrinolytic Agents; Guanidines; Guinea Pigs; Humans; Macaca fascicularis; Male; Pipecolic Acids; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrazines; Sulfonamides; Ticlopidine | 1996 |
Effects of TAK-029, a novel GPIIb/IIIa antagonist, on arterial thrombosis in guinea pigs, dogs and monkeys.
Topics: Animals; Basilar Artery; Bleeding Time; Carotid Artery Thrombosis; Coronary Thrombosis; Disease Models, Animal; Dogs; Female; Guanidines; Guinea Pigs; Injections, Intravenous; Macaca fascicularis; Male; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrazines; Thrombosis | 1997 |
Utilization of an amorphous form of a water-soluble GPIIb/IIIa antagonist for controlled release from biodegradable microspheres.
Topics: Animals; Arginine; Biocompatible Materials; Drug Delivery Systems; Fibrinolytic Agents; Guanidines; Lactic Acid; Male; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyrazines; Rats; Rats, Sprague-Dawley | 1997 |
Novel non-peptide fibrinogen receptor antagonists. 1. Synthesis and glycoprotein IIb-IIIa antagonistic activities of 1,3,4-trisubstituted 2-oxopiperazine derivatives incorporating side-chain functions of the RGDF peptide.
Topics: Animals; Drug Design; Fibrinogen; Guanidines; Guinea Pigs; Humans; In Vitro Techniques; Kinetics; Molecular Structure; Oligopeptides; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrazines; Structure-Activity Relationship | 1998 |
Platelet protective effect of TAK-029, a novel glycoprotein IIb/IIIa antagonist: an in vitro study.
Topics: beta-Thromboglobulin; Blood Platelets; Cardiopulmonary Bypass; Centrifugation; Fibrinolytic Agents; Guanidines; Humans; In Vitro Techniques; Models, Biological; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrazines; Stress, Mechanical | 1998 |
Rapid platelet-function assay: an automated and quantitative cartridge-based method.
Topics: Abciximab; Adenosine Diphosphate; Antibodies, Monoclonal; Autoanalysis; Guanidines; Humans; Immunoglobulin Fab Fragments; Nephelometry and Turbidimetry; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrazines; Radiometry; Time Factors | 1999 |
Adhesion of adenosine diphosphate-activated platelets to human brain microvascular endothelial cells under flow in vitro is mediated via GPIIb/IIIa.
Topics: Adenosine Diphosphate; Brain; Cells, Cultured; Endothelium, Vascular; Fibrinolytic Agents; Guanidines; Humans; Microcirculation; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrazines | 2001 |
Local glycoprotein IIb/IIIa receptor inhibitor delivery from the pump surface attenuates platelet adhesion in continuous flow ventricular assist devices.
Topics: Adsorption; Blood Platelets; Delayed-Action Preparations; Fibrinogen; Guanidines; Heart-Assist Devices; Hemorheology; Humans; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrazines | 2008 |